EMC9

Across TCGA patient cohorts, EMC9 mutation is significantly associated with the immune_cell of many other genes, with 3 significant associations in total. COAD shows the largest number of these associations.

The most reproducible EMC9-associated genes across cancer lineages are CD8+ T-cells, CD8+ Tcm, and CD4+ naive T-cells. Each is linked with EMC9 in more than 1 cancer types. Because this analysis shows association rather than direction, both EMC9-to-partner and partner-to-EMC9 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CD8+ T-cells grouped by EMC9-low versus EMC9-high in COAD.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (EMC9→partner) and Y-score (partner→EMC9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
COAD	CD8+ T-cells →	+0.089	+6.142	<.001	.027	3	2
COAD	CD8+ Tcm →	+0.151	+5.917	<.001	.032	3	2
COAD	CD4+ naive T-cells →	+0.047	+6.142	<.001	.027	3	1

Each partner links to its Q-omics profile. Showing the 3 strongest of 3 associations by consensus.

CD8+ T-cells by EMC9 expression — COAD

Explore this box plot interactively →